1. Home
  2. ICCM vs NEPH Comparison

ICCM vs NEPH Comparison

Compare ICCM & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.23

Market Cap

41.4M

Sector

N/A

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.57

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCM
NEPH
Founded
2006
1997
Country
Israel
United States
Employees
N/A
36
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.4M
34.0M
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
ICCM
NEPH
Price
$0.23
$3.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.50
$6.00
AVG Volume (30 Days)
547.4K
32.7K
Earning Date
05-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.01
Revenue
N/A
$18,789,000.00
Revenue This Year
$139.51
$11.24
Revenue Next Year
$75.66
$11.58
P/E Ratio
N/A
$360.00
Revenue Growth
N/A
32.67
52 Week Low
$0.22
$2.23
52 Week High
$1.40
$6.42

Technical Indicators

Market Signals
Indicator
ICCM
NEPH
Relative Strength Index (RSI) 29.04 56.99
Support Level N/A $2.79
Resistance Level $0.74 $3.78
Average True Range (ATR) 0.03 0.37
MACD 0.00 0.05
Stochastic Oscillator 8.24 75.34

Price Performance

Historical Comparison
ICCM
NEPH

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: